Company Overview of Hangzhou Longhill Bio-medication Technology Co., Ltd.
Hangzhou Longhill Bio-medication Technology Co., Ltd. develops and markets drugs and pharmaceuticals. It offers propionate, furoate, oxalate, disodium, bromide, zoledronic acid, peptide, glucagon, oxytocin, and triptorelin. The company is headquartered in Hangzhou, China. Hangzhou Longhill Bio-medication Technology Co., Ltd. operates as a subsidiary of Zhejiang Longhill Group Co., Ltd.
No.33 Xincheng Road
86 571 8897 7992
86 571 8897 7992
Key Executives for Hangzhou Longhill Bio-medication Technology Co., Ltd.
Similar Private Companies By Industry
|Zhejiang Ruibang Pharmaceutical Co., Ltd.||Asia|
|Adlai Nortye Biopharma Co., Ltd.||Asia|
|Aleph Biological Co., Ltd.||Asia|
|Allist Pharmaceuticals, Inc.||Asia|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|The Advertising Council, Inc.||United States|
|Tax Management Inc||United States|
|John F. Kennedy Center For The Performing Arts||United States|
|NYC2012, Inc.||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact Hangzhou Longhill Bio-medication Technology Co., Ltd., please visit www.longxiyy.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.